LEVONORGESTREL/ETHINYLESTRADIOL EG 150 micrograms/30 micrograms, coated tablet 63 tablets
Active ingredients: Levonorgestrel, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Coated tablet63 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVONORGESTREL/ETHINYLESTRADIOL EG 150 microgrammes/30 microgrammes, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) PVC PVDC aluminium de 21 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69204699CIP72798261CIP133400927982613Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVONORGESTRELcomprimé | 0,150 mg · un comprimé | SA |
| ÉTHINYLESTRADIOLcomprimé | 0,030 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.